Patent · US Expired

Pharmacological uses of azetidine derivatives

US6872717B2 · kind B2 · utility

16Cited by
3References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2002
Grant dateMar 29, 2005
Priority date
Expiry dateJan 29, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A method of treating or preventing obesity, this method comprising administering to a patient in need of such treatment an effective amount of a compound of formula in which R, R3 and R4 are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.